ITRM20010332A1 - Vaccini a subunita' e procedimenti per la loro produzione. - Google Patents

Vaccini a subunita' e procedimenti per la loro produzione.

Info

Publication number
ITRM20010332A1
ITRM20010332A1 IT2001RM000332A ITRM20010332A ITRM20010332A1 IT RM20010332 A1 ITRM20010332 A1 IT RM20010332A1 IT 2001RM000332 A IT2001RM000332 A IT 2001RM000332A IT RM20010332 A ITRM20010332 A IT RM20010332A IT RM20010332 A1 ITRM20010332 A1 IT RM20010332A1
Authority
IT
Italy
Prior art keywords
vaccines
extract
subunity
procedures
production
Prior art date
Application number
IT2001RM000332A
Other languages
English (en)
Inventor
Rosella Franconi
Colomba Giorgi
Aldo Venuti
Maria Luisa Marcante
Luisa Accardi
Bonito Paola Di
Francesco Dibello
Orsola Bitti
Original Assignee
Ist Superiore Sanita
Enea Ente Nuove Tec
Ist Fisioterap Ospitalroma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ist Superiore Sanita, Enea Ente Nuove Tec, Ist Fisioterap Ospitalroma filed Critical Ist Superiore Sanita
Priority to IT2001RM000332A priority Critical patent/ITRM20010332A1/it
Publication of ITRM20010332A0 publication Critical patent/ITRM20010332A0/it
Priority to EP02743621A priority patent/EP1401493B8/en
Priority to PCT/IT2002/000354 priority patent/WO2002102410A1/en
Priority to US10/480,616 priority patent/US20040161432A1/en
Priority to AT02743621T priority patent/ATE355078T1/de
Priority to DE60218463T priority patent/DE60218463D1/de
Publication of ITRM20010332A1 publication Critical patent/ITRM20010332A1/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
    • C12N15/8258—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon for the production of oral vaccines (antigens) or immunoglobulins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Mycology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
IT2001RM000332A 2001-06-11 2001-06-11 Vaccini a subunita' e procedimenti per la loro produzione. ITRM20010332A1 (it)

Priority Applications (6)

Application Number Priority Date Filing Date Title
IT2001RM000332A ITRM20010332A1 (it) 2001-06-11 2001-06-11 Vaccini a subunita' e procedimenti per la loro produzione.
EP02743621A EP1401493B8 (en) 2001-06-11 2002-05-31 Subunit vaccines and processes for the production thereof
PCT/IT2002/000354 WO2002102410A1 (en) 2001-06-11 2002-05-31 Subunit vaccines and processes for the production thereof
US10/480,616 US20040161432A1 (en) 2001-06-11 2002-05-31 Subunit vaccines and processes for the production thereof
AT02743621T ATE355078T1 (de) 2001-06-11 2002-05-31 Untereiheitsimpfstoffe und verfahren zur deren herstellung
DE60218463T DE60218463D1 (de) 2001-06-11 2002-05-31 Untereiheitsimpfstoffe und verfahren zur deren herstellung

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2001RM000332A ITRM20010332A1 (it) 2001-06-11 2001-06-11 Vaccini a subunita' e procedimenti per la loro produzione.

Publications (2)

Publication Number Publication Date
ITRM20010332A0 ITRM20010332A0 (it) 2001-06-11
ITRM20010332A1 true ITRM20010332A1 (it) 2002-12-11

Family

ID=11455591

Family Applications (1)

Application Number Title Priority Date Filing Date
IT2001RM000332A ITRM20010332A1 (it) 2001-06-11 2001-06-11 Vaccini a subunita' e procedimenti per la loro produzione.

Country Status (6)

Country Link
US (1) US20040161432A1 (it)
EP (1) EP1401493B8 (it)
AT (1) ATE355078T1 (it)
DE (1) DE60218463D1 (it)
IT (1) ITRM20010332A1 (it)
WO (1) WO2002102410A1 (it)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8101189B2 (en) 2002-07-05 2012-01-24 Folia Biotech Inc. Vaccines and immunopotentiating compositions and methods for making and using them
DK1523329T3 (da) * 2002-07-05 2013-10-14 Folia Biotech Inc Viruspartikeladjuvant
KR101034151B1 (ko) 2009-05-22 2011-05-13 서울대학교산학협력단 감자 바이러스 ｘ의 외피 단백질과 상호작용하는 담배 식물 니코티아나 벤타미아나 유래의 단백질
CN104059934B (zh) * 2014-05-11 2016-09-14 浙江大学 人乳头瘤病毒8e7蛋白表达及应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4956282A (en) * 1985-07-29 1990-09-11 Calgene, Inc. Mammalian peptide expression in plant cells
US5316931A (en) * 1988-02-26 1994-05-31 Biosource Genetics Corp. Plant viral vectors having heterologous subgenomic promoters for systemic expression of foreign genes
US5612487A (en) * 1991-08-26 1997-03-18 Edible Vaccines, Inc. Anti-viral vaccines expressed in plants
DE69533964T2 (de) * 1994-10-24 2006-03-30 The Texas A & M University System, College Station Orale immunisierung durch verwendung von transgenen pflanzen
IL147343A0 (en) * 1999-07-21 2002-08-14 Large Scale Biology Corp Method for enhancing ran or protein production using non-native 5' untranslated sequences in recombinant viral nucleic acids
KR100366608B1 (ko) * 2000-02-15 2003-01-09 마스터진(주) 형질전환 식물체로부터 생산된 재조합 인간 파필로마바이러스 백신
US6730306B1 (en) * 2000-03-08 2004-05-04 Large Scale Biology Corporation Parvovirus vaccine as viral coat protein fusions

Also Published As

Publication number Publication date
DE60218463D1 (de) 2007-04-12
EP1401493B1 (en) 2007-02-28
WO2002102410A1 (en) 2002-12-27
ITRM20010332A0 (it) 2001-06-11
EP1401493B8 (en) 2007-06-13
ATE355078T1 (de) 2006-03-15
EP1401493A1 (en) 2004-03-31
US20040161432A1 (en) 2004-08-19

Similar Documents

Publication Publication Date Title
IL150602A (en) Proteosome influenza vaccine, method for preparing such and use thereof
IL145982A0 (en) Vaccines
WO2001034801A3 (en) Recombinant gelatin in vaccines
IL172854A0 (en) Autologous self-tolerance inducing cells of monocytic origin and their use in pharmaceutical preparations
MY125202A (en) Vaccine
WO2005089164A3 (en) Inducing cellular immune responses to human papillomavirus using peptide and nucleic acid compositions
WO2001064922A3 (en) Heterologous expression of neisserial proteins
EP1246644A4 (en) INDUCTION OF CELLULAR IMMUNE RESPONSES TO HUMAN PAPILLOMA VIRUS USING PEPTIDES AND NUCLEIC ACID COMPOSITIONS
WO2005063820A3 (en) Il-7 fusion proteins
WO2006068663A3 (en) Vaccine compositions for treating coronavirus infection
NO20045521L (no) Diarylureaderivater anvendelige for behandling av proteinkinaseavhengige sykdommer
NO20031646L (no) Adjuvanssammensetning omfattende et immunostimulatorisk oligonukleotid og en tokol
WO2002018572A3 (en) Membrane penetrating peptides and uses thereof
WO2007052059A3 (en) Changing th1/th2 balance in split influenza vaccines with adjuvants
PT1409692E (pt) Novos péptidos do derivados da proteína g do vírus respiratório sincicial (vrs) e sua utilização numa vacina
WO2005013918A3 (en) Compositions, methods and kits relating to poxvirus subunit vaccines
DK1530637T3 (da) Carlsberg-subtilisin-proteiner med nedsat immunogenitet
WO2005047494A3 (en) Haematopoietic stem cells suitable for transplantation, their preparation and pharmaceutical compositions comprising them
WO2003015712A3 (en) Methods for preparing compositions comprising heat shock proteins or alpha-2-macroglobulin
WO2004037175A3 (en) Compositions and methods for treating human papillomavirus-mediated disease
DK1290160T3 (da) Humane Pellino-polypeptider
ITRM20010332A1 (it) Vaccini a subunita' e procedimenti per la loro produzione.
DE60218327D1 (de) Inaktivierte immunogene bakterielle ganzzell-zusammensetzungen
DK1438057T3 (da) Fyrrekogleekstrakter og anvendelser deraf
WO2001004143A3 (en) Prostase vaccine